720
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Non-fungible tokens as a framework for sustainable innovation in pharmaceutical R&D: a smart contract-based platform for data sharing and rightsholder protection

ORCID Icon, , , , , & show all
Pages 66-85 | Received 22 Dec 2022, Accepted 04 Jul 2023, Published online: 20 Jul 2023

References

  • Balasegaram, Manica, Peter Kolb, John McKew, Jaykumar Menon, Piero Olliaro, Tomasz Sablinski, Zakir Thomas, Matthew H Todd, Els Torreele, and John Wilbanks. 2017. “An Open Source Pharma Roadmap.” PLOS Medicine 14 (4): e1002276. https://doi.org/10.1371/journal.pmed.1002276.
  • Carroll, Michael W. 2015. “Sharing Research Data and Intellectual Property Law: A Primer.” PLOS Biology 13 (8): e1002235. https://doi.org/10.1371/journal.pbio.1002235.
  • Coase, R. H. 1960. “The Problem of Social Cost.” The Journal of Law and Economics 3 (July): 1–44. https://doi.org/10.1086/466560.
  • “Commentary: The Coronavirus Pandemic Has Shattered the Status Quo on Drug Development. We Should Build on That | Fortune.” 2020. 2020. https://fortune.com/2020/03/26/coronavirus-vaccine-drug-development-open-science-covid-19-treatment/.
  • Corrales, Marcelo, Mark Fenwick, and Helena Haapio. 2019. “Digital Technologies, Legal Design and the Future of the Legal Profession.” In Perspectives in Law, Business and Innovation. Singapore: Springer Nature. https://doi.org/10.1007/978-981-13-6086-2_1.
  • Corrales, Marcelo, Mark Fenwick, Helena Haapio, and Erik P M Vermeulen. 2019. “Tomorrow’s Lawyer Today? Platform-Driven LegalTech, Smart Contracts & the New World of Legal Design.” Journal of Internet Law 22 (10): 3–12.
  • Corrales, Marcelo, Paulius Jurčys, and George Kousiouris. 2019. “Smart Contracts and Smart Disclosure: Coding a GDPR Compliance Framework.” In Perspectives in Law, Business and Innovation. Singapore: Springer Nature. https://doi.org/10.1007/978-981-13-6086-2_8
  • Corrales Compagnucci, Marcelo. 2020. Big Data, Databases and “Ownership” Rights in the Cloud. Perspectives in Law, Business and Innovation. Singapore: Springer Nature.
  • Corrales Compagnucci, Marcelo, Eva Egermann, Nikolaus Forgó, and Tina Krügel. 2010. “Intellectual Property Rights in E-Health: Balancing out the Interests at Stake - A Herculean Task?” International Journal of Private Law 3 (3): 286–299. https://doi.org/10.1504/IJPL.2010.033409.
  • Corrales Compagnucci, Marcelo, Mark Fenwick, and Helena Haapio. 2019. Legal Tech, Smart Contracts and Blockchain. Perspectives in Law, Business and Innovation. Singapore: Springer Nature. https://doi.org/10.1007/978-981-13-6086-2.
  • Corrales Compagnucci, Marcelo, Mark Fenwick, and Stefan Wrbka. 2021. Smart Contracts: Technological, Business and Legal Perspectives. Oxford: Hart Publishing.
  • “Creative Commons — Attribution 4.0 International — CC BY 4.0.” n.d. Accessed July 12, 2023. https://creativecommons.org/licenses/by/4.0/.
  • “Creative Commons — CC0 1.0 Universal.” n.d. Accessed July 12, 2023. https://creativecommons.org/publicdomain/zero/1.0/.
  • Deloitte Centre for Health Solutions. 2022. “Nurturing Growth Measuring the Return from Pharmaceutical Innovation 2021,” no. January. https://www2.deloitte.com/content/dam/Deloitte/uk/Documents/life-sciences-health-care/Measuring-the-return-of-pharmaceutical-innovation-2021-Deloitte.pdf.
  • Deloitte US. 2017. “Collaboration as a Key to Success in Pharmaceutical R&D.” 2017. https://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/health-care-current-january17-2017.html.
  • Druedahl, Louise C., Timo Minssen, and W. Nicholson Price. 2021. “Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships.” Vaccine 39 (42): 6291–6295. https://doi.org/10.1016/j.vaccine.2021.08.101.
  • European Commission. 2016. “H2020 Programme. Guidelines on FAIR Data Management in Horizon 2020,” no. 3: 12. https://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/oa_pilot/h2020-hi-oa-data-mgt_en.pdf.
  • European Commission. 2018. Turning FAIR Into Reality: Final Report and Action Plan from the European Commission Expert Group on FAIR Data. Publications Office. https://doi.org/10.2777/1524.
  • “Final Report — High-Level Panel on Access to Medicines.” 2016. 2016. http://www.unsgaccessmeds.org/final-report/.
  • Gervais, Daniel. 2019. “Exploring the Interfaces Between Big Data and Intellectual Property Law.” Journal of Intellectual Property, Information Technology and E-Commerce Law. https://doi.org/10.2139/ssrn.3360344.
  • Gollman, Dieter. 1999. Computer Security. Hoboken: Wiley.
  • Graber-Soudry, Ohad, Timo Minssen, Daniel Nilsson, Jakob Wested, Marcelo Corrales Compagnucci, and Benedicte Illien. 2021. “Legal Interoperability and the FAIR Data Principles: An X-Officio Study Commissioned by the EOSC FAIR Working Group.” https://doi.org/10.5281/zenodo.4471312.
  • Heller, Stephen R., Alan McNaught, Igor Pletnev, Stephen Stein, and Dmitrii Tchekhovskoi. 2015. “InChI, the IUPAC International Chemical Identifier.” Journal of Cheminformatics 7 (1), https://doi.org/10.1186/s13321-014-0049-z.
  • Housley, Russell, et al. 1999. “RFC 2459 - Internet X.509 Public Key Infrastructure Certificate and CRL Profile.” https://datatracker.ietf.org/doc/html/rfc2459.html.
  • Kessel, Mark. 2011. “The Problems with Today’s Pharmaceutical Business—an Outsider’s View.” Nature Biotechnology 29 (1): 27–33. https://doi.org/10.1038/nbt.1748.
  • Kostick-Quenet, Kristin, Kenneth D. Mandl, Timo Minssen, I. Glenn Cohen, Urs Gasser, Isaac Kohane, and Amy L. McGuire. 2022. “How NFTs Could Transform Health Information Exchange.” Science 375 (6580): 500–502. https://doi.org/10.1126/science.abm2004.
  • Mayr, Lorenz M, and Dejan Bojanic. 2009. “Novel Trends in High-Throughput Screening.” Current Opinion in Pharmacology 9 (5): 580–588. https://doi.org/10.1016/j.coph.2009.08.004.
  • Mons, Barend, Cameron Neylon, Jan Velterop, Michel Dumontier, Luiz Olavo Bonino da Silva Santos, and Mark Wilkinson. 2017. “Cloudy, Increasingly FAIR; Revisiting the FAIR Data Guiding Principles for the European Open Science Cloud.” Information Services & Use 37 (February): 49–56. https://doi.org/10.3233/ISU-170824.
  • Nilsson, Niclas, and Jakob Felding. 2015. “Open Innovation Platforms to Boost Pharmaceutical Collaborations: Evaluating External Compounds for Desired Biological Activity.” Future Medicinal Chemistry 7 (14): 1853–1859. https://doi.org/10.4155/fmc.15.122.
  • Nilsson, Niclas, and Timo Minssen. 2018. “Unlocking the Full Potential of Open Innovation in the Life Sciences Through a Classification System.” Drug Discovery Today 23 (4): 771–775. https://doi.org/10.1016/j.drudis.2018.01.002.
  • Noorden, Richard Van. 2021. “Scientists Call for Fully Open Sharing of Coronavirus Genome Data.” Nature 590 (7845): 195–196. https://doi.org/10.1038/d41586-021-00305-7.
  • Oliva, Michele, and Marcelo Corrales. 2011. “Law Meets Biology: Are Our Databases Eligible for Legal Protection?” SCRIPTed 8 (3): 226. https://doi.org/10.2966/scrip.080311.226.
  • Olk, Paul, and Joel West. 2020. “The Relationship of Industry Structure to Open Innovation: Cooperative Value Creation in Pharmaceutical Consortia.” R&D Management 50 (1): 116–135. https://doi.org/10.1111/radm.12364.
  • Olsson, Christoffer, and Mohsen Toorani. 2021. “A Permissioned Blockchain-Based System for Collaborative Drug Discovery.” In ICISSP 2021 - Proceedings of the 7th International Conference on Information Systems Security and Privacy. https://doi.org/10.5220/0010236901210132.
  • “Open Data Commons Public Domain Dedication and License (PDDL) v1.0 — Open Data Commons: Legal Tools for Open Data.” n.d. Accessed July 12, 2023. https://opendatacommons.org/licenses/pddl/1-0/.
  • “Open-Source Malaria: OSM.” n.d. http://opensourcemalaria.org/.
  • “Open Targets: New Name, New Data | EMBL-EBI.” 2016. https://www.ebi.ac.uk/about/news/announcements/open-targets-new-name-new-data/.
  • Ostrom, Elinor. 2000. “Reformulating the Commons.” Swiss Political Science Review 6 (1): 29–52. https://doi.org/10.1002/j.1662-6370.2000.tb00285.x.
  • Ostrom, Elinor. 2015. Governing the Commons. Governing the Commons. Cambridge: Cambridge University Press. https://doi.org/10.1017/cbo9781316423936.
  • Saha, Chandra Nath, and Sanjib Bhattacharya. 2011. “Intellectual Property Rights: An Overview and Implications in Pharmaceutical Industry.” Journal of Advanced Pharmaceutical Technology & Research 2 (2): 88–93. https://doi.org/10.4103/2231-4040.82952.
  • Saluja, Ronak, Vanessa Arciero, Sierra Cheng, Erica McDonald, William Wong, Matthew Cheung, and Kelvin Chan. 2018. “Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over Time.” Journal of Oncology Practice 14 (March): e280–e294. https://doi.org/10.1200/JOP.17.00058.
  • Schuhmacher, Alexander, Oliver Gassmann, and Markus Hinder. 2016. “Changing R&D Models in Research-Based Pharmaceutical Companies.” Journal of Translational Medicine 14 (1): 105. https://doi.org/10.1186/s12967-016-0838-4.
  • “SGC | Structural Genomics Consortium.” n.d. Accessed July 11, 2023. https://www.thesgc.org/.
  • Tsarsitalidis, Stylianos, Marcelo Corrales Compagnucci, George Kousiouris, and Alan Dahi. 2021. “Feeding Smart Contract Legal Requirements with Semantic and Event Detection Logic Structures from Modern Service-Oriented Supply Chains.” In Smart Contracts: Technological, Business and Legal Perspectives, edited by Marcelo Corrales Compagnucci, Mark Fenwick, and Stefan Wrbka. Oxford: Hart Publishing. https://doi.org/10.5040/9781509937059.ch-007.
  • Weininger, David. 1988. “SMILES, a Chemical Language and Information System: 1: Introduction to Methodology and Encoding Rules.” Journal of Chemical Information and Computer Sciences 28 (1): 31–36. https://doi.org/10.1021/ci00057a005.
  • “What Is An NFT? – Forbes Advisor.” n.d. Accessed July 9, 2023. https://www.forbes.com/advisor/investing/cryptocurrency/nft-non-fungible-token/.
  • Wilkinson, Mark D., Michel Dumontier, IJsbrand Jan Aalbersberg, Gabrielle Appleton, Myles Axton, Arie Baak, Niklas Blomberg, et al. 2016. “The FAIR Guiding Principles for Scientific Data Management and Stewardship.” Scientific Data 3 (1): 160018. https://doi.org/10.1038/sdata.2016.18.